logo

Bristol-Myers Squibb Co. (BMY)



Trade BMY now with
  Date
  Headline
9/22/2017 7:00:06 AM AbbVie, Bristol-Myers Squibb Announce Research Collaboration To Evaluate Therapeutic Regimen In Advanced Solid Tumors
9/22/2017 5:03:46 AM Bristol-Myers Squibb: Japanese Ministry Of Health, Labor And Welfare Approve Opdivo (nivolumab)
9/14/2017 7:00:00 AM Bristol-Myers Squibb And Halozyme Enter Global Collaboration And License Agreement For ENHANZE Technology
9/14/2017 6:59:55 AM Bristol-Myers Squibb And Halozyme Therapeutics Announce Global Collaboration And License Agreement
9/13/2017 4:36:08 PM Bristol-Myers Squibb Declares Quarterly Dividend Of $0.39, Payable Nov. 1/ Record Oct. 6
9/13/2017 4:32:14 PM Bristol-Myers Squibb Co. (BMY) Declares Quarterly Dividend of $ 0.39, Record Date 10/6/2017
9/13/2017 4:17:18 PM Bristol-Myers Squibb Names Karen Vousden To Board Of Directors
9/10/2017 12:21:10 PM Bristol-Myers Reports Results From Phase 3 CheckMate -214 Trial On Opdivo Plus Yervoy
9/8/2017 5:37:12 AM Bristol-Myers Squibb Announce 3-year Overall Survival Data From CheckMate -017 And CheckMate -057
9/7/2017 4:30:27 PM Bristol-Myers Squibb Completes Acquisition Of IFM Therapeutics
9/7/2017 7:00:49 AM Bristol-Myers Squibb Says Phase 3 Study Evaluating Opdivo Plus Yervoy Met Its Co-primary Endpoint